Cited by 33Neurogenesis and neuroplasticity mechanismsCell death mechanisms and regulationMultiple Sclerosis Research Studies

Oligodendrocyte Maturation Alters the Cell Death Mechanisms That Cause Demyelination

Open access
Chapman, Timothy W., Kamen, Yasmine, Piedra, Enrique T., Hill, Robert A.·2024·The Journal of Neuroscience

Published version of a preprint

Abstract

Myelinating oligodendrocytes die in human disease and early in aging. Despite this, the mechanisms that underly oligodendrocyte death are not resolved and it is also not clear whether these mechanisms change as oligodendrocyte lineage cells are undergoing differentiation and maturation. Here, we used a combination of intravital imaging, single-cell ablation, and cuprizone-mediated demyelination, in both female and male mice, to discover that oligodendrocyte maturation dictates the dynamics and mechanisms of cell death. After single-cell phototoxic damage, oligodendrocyte precursor cells underwent programmed cell death within hours, differentiating oligodendrocytes died over several days, while mature oligodendrocytes took weeks to die. Importantly cells at each maturation stage all eventually died but did so with drastically different temporal dynamics and morphological features. Consistent with this, cuprizone treatment initiated a caspase-3–dependent form of rapid cell death in differentiating oligodendrocytes, while mature oligodendrocytes never activated this executioner caspase. Instead, mature oligodendrocytes exhibited delayed cell death which was marked by DNA damage and disruption in poly-ADP-ribose subcellular localization. Thus, oligodendrocyte maturation plays a key role in determining the mechanism of death a cell undergoes in response to the same insult. This means that oligodendrocyte maturation is important to consider when designing strategies for preventing cell death and preserving myelin while also enhancing the survival of new oligodendrocytes in demyelinating conditions.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.1794-23.2024

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BCAS1 + GFP+ oligodendrocytes represent a relatively more mature differentiating oligodendrocyte state than BCAS1 + GFP- cells.

    “BCAS1 + GFP+ oligodendrocytes should represent a relatively more mature differentiating oligodendrocyte state than BCAS1 + GFP‐ cells (Chapman et al. 2024; Hughes et al. 2018; Orthmann‐Murphy et al. 2020).”
  • BCAS1 is expressed by newly differentiated, pre-myelinating, and early-myelinating oligodendrocytes that derive from NG2+ OPCs but do not yet express all mature oligodendrocyte markers.

    “Recent studies showed that BCAS1 (breast carcinoma amplified sequence 1) is expressed by a subset of the oligodendrocyte lineage: newly differentiated, pre‐myelinating, and early‐myelinating oligodendrocytes that derive from NG2+ OPCs but do not yet express all mature oligodendrocyte markers (Chapman et al. 2024; Fard et al. 2017).”
  • BCAS1+ cells die by a caspase-3 dependent mechanism.

    “Most of these differentiating cells likely died by apoptosis; BCAS1+ cells were recently shown to die by a caspase‐3 dependent mechanism (Chapman et al. 2024).”
  • The early oligodendrocyte cell population may rapidly mobilize to compensate for oligodendrocyte loss following cuprizone administration, but the continued presence of cuprizone precludes the survival and maturation of the new oligodendrocytes.

    “Together, these findings indicate that the early oligodendrocyte cell population may rapidly mobilize to compensate for the oligodendrocyte loss following cuprizone administration, but the continued presence of cuprizone precludes the survival and maturation of the new oligodendrocytes [42].”

The citation lists haven’t been fetched yet

References 85 · Cited by 33

Authors
Chapman, T. W., Kamen, Y., Piedra, E. T., & Hill, R. A.
Affiliations
Dartmouth College (US)
Venue
The Journal of Neuroscience
Published
2024-02-23
Volume
44
Issue
13
Pages
e1794232024
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W4392094192
Cited by
33
References
85
Citations by year
2026: 16 · 2025: 11 · 2024: 6
FWCI
5.40
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS122800)
  • Esther A. and Joseph Klingenstein Fund
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
Keywords
oligodendrocyte maturation, demyelination, oligodendrocyte death, programmed cell death, cuprizone, caspase-3, DNA damage, poly(ADP-ribose), oligodendrocyte precursor cells, myelination, intravital imaging
MeSH terms
Animals, Cell Differentiation, Cuprizone, Demyelinating Diseases, Female, Humans, Male, Mice, Inbred C57BL, Myelin Sheath, Oligodendroglia, Apoptosis, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review